Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01372254 · ClinicalTrials.gov registry record · Phase 1
Behavioral Intervention for Low Income Depressed Smokers in Drug Treatment
A Phase 1 study, sponsored by University of Maryland, College Park.
- Completed
- Registry status
- Phase 1
- Development phase
- 96
- Enrollment target
NCT01372254: Completed Phase 1 study, sponsored by University of Maryland, College Park.
NCT01372254 is a Phase 1 study that has completed, run by University of Maryland, College Park. The registered enrollment target is 96 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (60% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01372254, a Phase 1 study, has completed, sponsored by University of Maryland, College Park.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 96 participants
- Enrollment target
Study Summary
The objective of the proposed project is to develop a novel, behavioral approach to smoking cessation that can be integrated with residential drug use treatment for low income substance using smokers with elevated depressive symptoms. The approach utilizes behavioral activation strategies which have been shown to reduce smoking among community samples and which can be easily targeted for the particular needs of low income substance users.
Primary Outcome
7 days of smoking abstinence confirmed biochemically at 26 weeks
Interventions
- DRUG Transdermal Nicotine Patch
- BEHAVIORAL Standard Treatment
- BEHAVIORAL BAD-AS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2011-12 |
| Est. Completion | 2015-05 |
| Phase | Phase 1 |
What the finished NCT01372254 record still lists
NCT01372254 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (60% higher).
The record links to 0 conditions, and to 3 interventions - of which Transdermal Nicotine Patch is the first listed.
NCT01372254 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01372254 about?
NCT01372254 is a clinical study titled "Behavioral Intervention for Low Income Depressed Smokers in Drug Treatment". The objective of the proposed project is to develop a novel, behavioral approach to smoking cessation that can be integrated with residential drug use treatment for low income substance using smokers with elevated depressive symptoms. The approach utilizes behavioral activation strategies which have...
What is the current status of trial NCT01372254?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 96 participants. The study started on 2011-12. Estimated completion is 2015-05.
What interventions are being tested in trial NCT01372254?
The interventions under investigation include: Transdermal Nicotine Patch (DRUG), Standard Treatment (BEHAVIORAL), BAD-AS (BEHAVIORAL).
Who is sponsoring clinical trial NCT01372254?
This trial is sponsored by University of Maryland, College Park, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01372254's enrollment target sits among peer trials
96 600th of 2000 higher than 1,391 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia